Vijay Shreedhar SEC EDGAR Filings (CIK 0001778051)

SEC EDGAR filings, ownership reports, and insider transactions for Vijay Shreedhar.

Business address
C/O Adamas Pharmaceuticals, Inc., 1900 Powell Street, Suite 1000, Emeryville, CA, 94608
Get insider transactions for this reporting owner
Vijay Shreedhar has filed 8 SEC EDGAR filings since 04 Jun 2019

Latest Filings

Recent SEC filings for Vijay Shreedhar including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 24 Nov 2021 24 Nov 2021 001-36399
4 Open 4 document View SEC filing for 4 FORM 4 23 Jun 2021 21 Jun 2021 001-36399
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 23 Mar 2021 22 Mar 2021 001-36399
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Mar 2021 02 Mar 2021 001-36399
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 01 Feb 2021 01 Feb 2021 001-36399
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 19 Mar 2020 17 Mar 2020 001-36399
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 07 Jun 2019 07 Jun 2019 001-36399
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 04 Jun 2019 28 May 2019 001-36399

About this filer

Vijay Shreedhar files with the SEC under CIK 0001778051. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages